Zhiyao Yuanchuang is an AI macromolecular drug design service provider. Its objective is to leverage generative AI technology to develop breakthrough drug screening algorithms.
Every round, secondary, debt facility or acquisition involving Zhiyao Yuanchuang that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.